Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
28.61
+0.06 (0.21%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $4.57 billion as of September 18, 2026. Its market cap has increased by 133.90% in one year.
Market Cap
4.57B
Enterprise Value
4.60B
1-Year Change
133.90%
Ranking
Category
Stock Price
$28.61
ChartMarket Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $4.57B, a decrease of -4.37%. That is a compound annual growth rate of -0.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 4.57B | 84.17% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qiagen | 8.96B |
| RadNet | 5.98B |
| Sotera Health Company | 5.35B |
| BillionToOne | 5.00B |
| GRAIL | 3.61B |
| Veracyte | 3.20B |
| GeneDx Holdings | 3.02B |
| CareDx | 2.78B |